FOXM1 and hepatocellular carcinoma: Kaplan–Meier survival analysis revealed the overexpression of FOXM1 was significantly related with the poor prognosis of HCC patients (Fig. 4B), especially in sorafenib treated HCC patients (Fig. 4C).